GUMM - Eliminate the Common Cold Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: sun who wrote (758)	8/6/1999 9:44:00 PM
From: out_of_the_loop	Read Replies (1) of 5582

I thought there were good things in the interview but it was quite light on Zicam and concentrated mostly on gums that have been made by GumTech. In addition, I do not think I heard the word "nicotine". They are very careful not to hype, in contrast to previous GUMM executives. Interesting facts included that Acutrim is the #2 selling diet product in the country. Also, they believe they are several years ahead of any other US companies wanting to develop specialized gum products. There are some European companies that do similar things. Other big companies will not compete unless products have over $50-100 million potential, so they won't compete until GUMM has already established products - an interesting catch-22 that may actually work for, rather than against GUMM. Networks of distribution for Zicam include 16 master brokers with their 200-300 sales people under them. In Israel, they have over $1 million in gum sales (no time period given). In general, I think the interview was typical of the new GUMM executive stance - very conservative.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next